EPL LIMITED Share Price Today - Live EPL Stock Price for NSE/BSE
NiveshIQ
NSE: EPL · Capital Goods
EPL Ltd.
₹234.44▼ ₹0.63 (-0.27%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on EPL. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About EPL Ltd.
EPL Limited is a leading manufacturer and seller of plastic packaging materials, serving the beauty and cosmetics, health and pharmaceuticals, food, home, and oral care industries. The company offers a diverse range of products, including multilayer collapsible tubes, corrugated boxes, laminates, dispensing systems, caps and closures, and printing technologies. EPL Limited has a strong presence in the Americas, Europe, Africa, the Middle East, South Asia, and the East Asia Pacific, with a global customer base. In 2020, the company underwent a name change from Essel Propack Limited to EPL Limited. The company's revenue stood at ₹4568 Cr, with a net income of ₹400 Cr. EPL Limited has been in the news for its mega merger with Indorama, which is expected to make it a leading player in the pack
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,916 Cr +6.00% | ₹4,212 Cr +7.60% | ₹4,763 Cr +13.10% |
| EBITDA Margin | 18.23% | 19.82% | 21.18% |
| Net Profit | ₹210.00 Cr -9.10% | ₹364.00 Cr +73.30% | ₹393.90 Cr +8.20% |
| EPS | ₹6.71 | ₹11.26 | ₹12.15 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
EPL Limited (EPL.NS) Stock Forecast 2027, 2031 & 7-Year Price Prediction | Meyka AI
🔒
Sign in to see AI summaries
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹1, 300 Cr, PAT ₹103 Cr, EPS ₹3.22, EBITDA margin 20.4%. Growth context: revenue QoQ +13.2%, PAT QoQ +24.5%. Street verdict: miss, revenue surprise +1.8%, PAT surprise -5.6%.
Volume growth, premiumisation, distribution reach, same-store throughput, and gross-margin discipline remain the key for...
FY26 (last completed FY): revenue ₹4, 763 Cr, PAT ₹394 Cr, EBITDA margin 21.2%, EPS ₹12.15. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for EPL
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track EPL alongside your other holdings
Unlock full EPL research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for EPL Ltd.?
NiveshIQ detects active intelligence signals for EPL Ltd. (EPL) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for EPL Ltd.?
EPL Ltd. operates in the Capital Goods sector with a market capitalisation of ₹677,295.4L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.